Meredith Giuliani, Thoracic Section Editor, Associate Professor of Radiation Oncology, and Associate Dean of Postgraduate Medical Education at the University of Toronto, practicing at the Princess Margaret Cancer Center Dr. Radiation Fractionation and Toxicity in Chemoradiotherapy for Non-Small Cell Lung Cancerĭr. Thomas Boike, the US Chief Medical Officer for Theranostics for GenesisCare, to discuss with us the real-world experience of bringing RPT into radiation oncology practices. Paul Wallner, Senior Vice President of Medical Affairs at GenesisCare USA and first author of another editorial this month, " Radiation Oncologists and Therapeutic Radiopharmaceuticals: Will History Repeat Itself?". Louis, and supervising author of an editorial we are publishing this month, " Radiation Oncology and Radiopharmaceuticals: Making our own history while learning from the past – An editorial response." We also host Dr. Jeff Michalski, President of ASTRO and Carlos Perez Distinguished Professor and Vice Chair of the Department of Radiation Oncology at Washington University in St. Sue Yom hosts a discussion this month on the status of radiopharmaceutical therapy (RPT) in radiation oncology. Past and Future of Radiopharmaceutical Therapy in Radiation OncologyĮditor-in-Chief Dr. PENTEC: Pediatric Normal Tissue Effects in the Clinic.
0 Comments
Leave a Reply. |